Apyx Medical (NASDAQ:APYX – Get Free Report) and Allurion Technologies (NYSE:ALUR – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership.
Analyst Ratings
This is a breakdown of current ratings and recommmendations for Apyx Medical and Allurion Technologies, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Apyx Medical | 1 | 1 | 3 | 1 | 2.67 |
| Allurion Technologies | 1 | 1 | 1 | 0 | 2.00 |
Apyx Medical presently has a consensus price target of $6.50, suggesting a potential upside of 69.27%. Allurion Technologies has a consensus price target of $3.00, suggesting a potential upside of 328.57%. Given Allurion Technologies’ higher possible upside, analysts plainly believe Allurion Technologies is more favorable than Apyx Medical.
Earnings & Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Apyx Medical | $52.84 million | 3.04 | -$11.21 million | ($0.22) | -17.45 |
| Allurion Technologies | $17.21 million | 0.61 | -$7.20 million | ($10.56) | -0.07 |
Allurion Technologies has lower revenue, but higher earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Allurion Technologies, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 21.4% of Allurion Technologies shares are held by institutional investors. 15.2% of Apyx Medical shares are held by insiders. Comparatively, 8.1% of Allurion Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Volatility and Risk
Apyx Medical has a beta of 1.35, indicating that its share price is 35% more volatile than the S&P 500. Comparatively, Allurion Technologies has a beta of -0.18, indicating that its share price is 118% less volatile than the S&P 500.
Profitability
This table compares Apyx Medical and Allurion Technologies’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Apyx Medical | -16.40% | -88.47% | -14.94% |
| Allurion Technologies | -199.96% | N/A | -77.13% |
Summary
Apyx Medical beats Allurion Technologies on 11 of the 15 factors compared between the two stocks.
About Apyx Medical
Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
About Allurion Technologies
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.
